Author

Marie Engvall

Observed names: Engvall, Marie, M. Engvall

Observed institutions: Uppsala University, Uppsala University Hospital, Science for Life Laboratory

ORCID: 0000-0002-7394-9191

Observed ORCID: 0000-0002-7394-9191

OpenAlex ID: A5039664282

Prognostic scoring systems for myelodysplastic syndromes ( MDS ) in a population‐based setting: a report from the Swedish MDS register

2018 · Daniel Moreno Berggren, Yasin Folkvaljon, et al. · British Journal of Haematology · 49

PDF

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study

2022 · Helen E. White, Matthew Salmon, et al. · Leukemia · 40

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

2021 · Sylvain Mareschal, Anna Palau, et al. · Blood Advances · 32

Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics

2020 · Marie Engvall, Nicola Cahill, et al. · BMC Medical Genomics · 31

PDF

Clonal haematopoiesis as a risk factor for therapy‐related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo‐(immuno)therapy

2022 · Maria‐Teresa Voso, Tatjana Pandzic, et al. · British Journal of Haematology · 25

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

2015 · S. Bhoi, P. Baliakas, et al. · Haematologica · 23

Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

2022 · Tatjana Pandzic, Claes Ladenvall, et al. · HemaSphere · 21

Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia

2025 · Emma L. Boertjes, Christian M. Vonk, et al. · Blood Advances · 16

PDF

Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population‐based study

2020 · Daniel Moreno Berggren, Matilda Kjellander, et al. · British Journal of Haematology · 14

PDF

Familial platelet disorder due to germline exonic deletions in RUNX1 : a diagnostic challenge with distinct alterations of the transcript isoform equilibrium

2022 · Marie Engvall, Ylva Karlsson, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13

PDF

Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial

2023 · Ulrika Norén-Nyström, Mette K. Andersen, et al. · HemaSphere · 10

Cytogenetic aberrations in adult acute lymphoblastic leukemia—A population‐based study

2021 · Emma Bergfelt Lennmyr, Marie Engvall, et al. · eJHaem · 10

PDF

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

2023 · Anna Eriksson, Marie Engvall, et al. · Clinical Cancer Research · 7

Validation of Prognostic Scoring Systems for Myelodysplastic Syndromes in the Swedish Mds-register

2016 · Daniel Moreno Berggren, Yasin Folkvaljon, et al. · Haematologica · 1

Ultra-Sensitive DNA-Based NPM1 Mutation Detection Using superRCA on Flow Cytometry

2026 · Ann-Sofi Johansson, Su-Chen Li, et al. · Genes

SuperRCA assay of KIT p.D816V mutation load reveals novel correlation to clinical phenotype

2026 · Cecilia Karlström, Monika Klimkowska, et al. · Journal of Allergy and Clinical Immunology Global

Supplementary Table 2 from Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

2025 · Anna Eriksson, Marie Engvall, et al.

Supplementary Data 1 from Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

2025 · Anna Eriksson, Marie Engvall, et al.

PDF

Supplementary Table1 from Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

2025 · Anna Eriksson, Marie Engvall, et al.

Data from Somatic exonic deletions in RUNX1 constitutes a novel recurrent genomic abnormality in acute myeloid leukemia